[1]
S.-H. Shin, “Inhibiting Sphingosine Kinase 2 Derived-sphingosine-1-phosphate Ameliorates Psoriasis-like Skin Disease via Blocking Th17 Differentiation of Naïve CD4 T Lymphocytes in Mice”, Acta Derm Venereol, vol. 99, no. 6, pp. 594–601, Mar. 2019.